Literature DB >> 8023819

Recurrent diseases in the kidney transplant.

E L Ramos1, C C Tisher.   

Abstract

Virtually all diseases affecting the native kidney recur in the kidney transplant with the exception of Alport syndrome, polycystic kidney disease, hypertension, chronic pyelonephritis, and chronic interstitial nephritis. Fortunately, in the majority of patients, recurrence of the original disease has minimal clinical impact, with only approximately 5% of all graft loss occurring as a result of recurrent disease. The primary renal diseases that commonly recur include membranoproliferative glomerulonephritis type II, IgA nephropathy, and focal and segmental glomerular sclerosis. The most common systemic disease that recurs is diabetic nephropathy. Living-related transplantation should be used with caution in patients with the hemolytic uremic syndrome, recurrent focal and segmental glomerular sclerosis, and membraneous glomerulonephritis. Fabry disease and primary hyperoxaluria type I are no longer absolute contraindications to kidney transplantation.

Entities:  

Mesh:

Year:  1994        PMID: 8023819     DOI: 10.1016/s0272-6386(12)80172-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

Review 1.  Living donor kidney transplantation in patients with hereditary nephropathies.

Authors:  Patrick Niaudet
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

Review 2.  Focal segmental glomerulosclerosis.

Authors:  I Ichikawa; A Fogo
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

3.  Preoperative Low-Density Lipoprotein Apheresis for Preventing Recurrence of Focal Segmental Glomerulosclerosis after Kidney Transplantation.

Authors:  Akihito Sannomiya; Toru Murakami; Ichiro Koyama; Kosaku Nitta; Ichiro Nakajima; Shohei Fuchinoue
Journal:  J Transplant       Date:  2018-04-02

4.  Renal transplant in a child with bilateral Wilms' tumor national premiere.

Authors:  Ioanel Sinescu; Mihai Hârza; Bogdan Serbănescu; Constantin Gîngu; Bogdan Stefan; Cătălin Dudu
Journal:  J Med Life       Date:  2008 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.